Patent Foramen Ovale Implying Paradoxical Embolism as a New Insight in Cryptogenic Stroke
Cerebrovascular thromboembolism is responsible annually for 510.000 ischaemic stroke in the united states alone. PFO mechanism as a paradoxical embolism transit from right to left-sided chambers to intracranial vessels has a tremendous impact in neurological deficits. The aggressive treatment start...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Indonesian Heart Association
2021-09-01
|
| Series: | Majalah Kardiologi Indonesia |
| Subjects: | |
| Online Access: | https://ijconline.id/index.php/ijc/article/view/1152 |
| id |
doaj-a182ae9733fa4910852d0e8028cee915 |
|---|---|
| record_format |
Article |
| spelling |
doaj-a182ae9733fa4910852d0e8028cee9152021-09-18T09:18:34ZengIndonesian Heart AssociationMajalah Kardiologi Indonesia0126-37732620-47622021-09-01423Patent Foramen Ovale Implying Paradoxical Embolism as a New Insight in Cryptogenic StrokeIndah Aprianti Putri0RS Pusat Otak Nasional Cerebrovascular thromboembolism is responsible annually for 510.000 ischaemic stroke in the united states alone. PFO mechanism as a paradoxical embolism transit from right to left-sided chambers to intracranial vessels has a tremendous impact in neurological deficits. The aggressive treatment started since 2016 when the US Food and Drug Administration (FDA) approved the Amplatzer PFO occluder for recurrent stroke prevention of cryptogenic stroke with PFO. The trials show positive results since 2017 and the collaboration and partnership between neurologist and cardiologist are more needed to build a holistic and comprehensive treatment for cryptogenic stroke patient with PFO. https://ijconline.id/index.php/ijc/article/view/1152PFOCryptogenic stroke |
| collection |
DOAJ |
| language |
English |
| format |
Article |
| sources |
DOAJ |
| author |
Indah Aprianti Putri |
| spellingShingle |
Indah Aprianti Putri Patent Foramen Ovale Implying Paradoxical Embolism as a New Insight in Cryptogenic Stroke Majalah Kardiologi Indonesia PFO Cryptogenic stroke |
| author_facet |
Indah Aprianti Putri |
| author_sort |
Indah Aprianti Putri |
| title |
Patent Foramen Ovale Implying Paradoxical Embolism as a New Insight in Cryptogenic Stroke |
| title_short |
Patent Foramen Ovale Implying Paradoxical Embolism as a New Insight in Cryptogenic Stroke |
| title_full |
Patent Foramen Ovale Implying Paradoxical Embolism as a New Insight in Cryptogenic Stroke |
| title_fullStr |
Patent Foramen Ovale Implying Paradoxical Embolism as a New Insight in Cryptogenic Stroke |
| title_full_unstemmed |
Patent Foramen Ovale Implying Paradoxical Embolism as a New Insight in Cryptogenic Stroke |
| title_sort |
patent foramen ovale implying paradoxical embolism as a new insight in cryptogenic stroke |
| publisher |
Indonesian Heart Association |
| series |
Majalah Kardiologi Indonesia |
| issn |
0126-3773 2620-4762 |
| publishDate |
2021-09-01 |
| description |
Cerebrovascular thromboembolism is responsible annually for 510.000 ischaemic stroke in the united states alone. PFO mechanism as a paradoxical embolism transit from right to left-sided chambers to intracranial vessels has a tremendous impact in neurological deficits. The aggressive treatment started since 2016 when the US Food and Drug Administration (FDA) approved the Amplatzer PFO occluder for recurrent stroke prevention of cryptogenic stroke with PFO. The trials show positive results since 2017 and the collaboration and partnership between neurologist and cardiologist are more needed to build a holistic and comprehensive treatment for cryptogenic stroke patient with PFO.
|
| topic |
PFO Cryptogenic stroke |
| url |
https://ijconline.id/index.php/ijc/article/view/1152 |
| work_keys_str_mv |
AT indahapriantiputri patentforamenovaleimplyingparadoxicalembolismasanewinsightincryptogenicstroke |
| _version_ |
1717377002186473472 |